The pattern of X-chromosome inactivation (XCIP), or Lyonization, can be used to distinguish monoclonal from polyclonal cell populations in females. However, a skewed XCIP exists in hematopoietic cells in approximately 40% of healthy elderly females, interfering with interpretation of clonality assays. In hematopoiesis, an active stem cell pool is assumed to be present within a larger population of inactive stem cells, with a continuous exchange of cells between the two compartments. The assumption that the active stem cell pool size decreases with age may explain the phenomenon of acquired skewing occurring by chance and predicts the XCIP of this population to fluctuate. This fluctuation should be reflected in the XCIP of peripheral granulocytes. We examined the XCIP for fluctuations in time in peripheral granulocytes, monocytes and T cells of young, middle-aged and elderly healthy females. We used an optimized HUMARA PCR assay that eliminates unbalanced DNA amplification. We found no fluctuations in XCIP in any age group in up to 18 months follow-up. We conclude that acquired skewing arises gradually in life without fluctuations in XCIP and that analysis at multiple time points cannot distinguish monoclonal hematopoiesis from normal, skewed hematopoiesis.
Introduction
Lyonization has had the interest of oncologists since it was shown that it could be used to assess the clonality of a population of (malignant) cells. The process of Lyonization, or Xchromosome inactivation, takes place early in embryogenesis in all females. 1 In every cell one of the two X-chromosomes is inactivated, presumably to correct for the level of expression of X-linked genes. Once one of the X-chromosomes has been inactivated randomly, the progeny of that cell inherits the Xchromosome inactivation pattern (XCIP). As a result most cell populations show a 50:50 distribution of inactivated paternal and inactivated maternal alleles. Malignant cells are derived from a single cell and although different subclones may develop, all malignant cells in a female patient will share the same inactivated X-allele. This principle has been used to investigate tumors, both solid and hematopoietic. 2, 3 The most frequently used clonality assay is based on a polymorphism in the human androgen receptor (HUMARA) gene. The polymorphism consists of a varying number of CAG repeats (17) (18) (19) (20) (21) (22) (23) (24) (25) (26) (27) (28) (29) (30) in the first exon of the gene. It has been shown that about 90% of the female population is heterozygous at this locus. 4 After PCR amplification of this locus, the two alleles are present as two PCR products of different size. Discrimination between active and inactive alleles can be made by digestion of the DNA with a methylation-sensitive restric- tion enzyme, such as HpaII, before PCR. Since the inactivated X-chromosome is heavily methylated, it will not be digested, and only the inactivated allele will serve as a template for the PCR.
In the last few years several technical difficulties have been described for this assay. It has been shown that both saline contaminants and the number of cycles can influence the ratio of PCR products. 5, 6 Both result in falsely skewed inactivation patterns. In this study, we show that the amplification of genomic DNA is also subject to preferential amplification with respect to the methylation status of the DNA. We also show that digesting the DNA with a restriction enzyme that is not sensitive to methylation can reverse this unequal amplification of genomic DNA.
Another limitation for the use of XCIP for clonality assays is acquired skewing. Once a population of cells has a certain distribution of alleles after Lyonization, this pattern has been assumed not to change. However, several reports have shown an increase in the number of females with a skewed XCIP in blood leukocytes with increasing age. [7] [8] [9] [10] [11] The percentage of females with a ratio of more than 75% of either allele in granulocytes may be as high as 40% after the age of 65. The skewing in T cells seems to lag behind, which may give rise to a different XCIP for T cells and granulocytes. Precisely this pattern, skewed granulocytes with non-skewed T cells, is thought to be indicative of malignant clonal myelopoiesis in patients with acute myeloid leukemia (AML), myelodysplastic syndrome (MDS) and myeloproliferative disorders (MPD). [12] [13] [14] [15] Studies in mice have shown that hematopoiesis is maintained by relatively few stem cells at any given time point (ෂ5% of all long-term self-renewing hematopoietic stem cells), while the vast majority (ෂ99%) of stem cells divides at least once during a longer period (57 days in mice). 16 This suggests a small percentage of active stem cells within the stem cell pool, and that stem cells are switching between active and inactive status. If we assume that the size of the active stem cell pool decreases with age, it is conceivable that fluctuations in the XCIP of the active stem cells may occur. The frequency of these fluctuations would reflect the time that a stem cell contributes to hematopoiesis. This fluctuation should also be apparent in the XCIP of peripheral granulocytes as these cells have a limited life span of several days. Furthermore, this fluctuation should not be present in clonal, malignant hematopoiesis. To test this hypothesis, we assessed the XCIP of granulocytes as well as T cells and monocytes of young, middle-aged and elderly females over a prolonged observation period. We show that no significant XCIP changes occur in any of three age groups for a period as long as 18 months. We also show in elderly females an increase in the number of individuals with a skewed XCIP as well as an increase in the degree of skewing. These results suggest that the observed acquired skewing affects the whole of the stem cell population and that it develops gradually during life. These results also implicate that analyses at multiple time points cannot distinguish clonal hematopoiesis from polyclonal hematopoiesis with a skewed XCIP.
Materials and methods

Selection of granulocytes, monocytes and T cells from healthy donors
Peripheral blood samples were obtained from 35 healthy blood donors after written, informed consent was obtained. All blood samples were separated in polymorphic nucleated cells (PMNC) and mononuclear cells (MNC) using Ficoll 1.077 density gradient centrifugation. MNC were cryopreserved prior to cell sorting. PMNC were recovered from the pellet of the gradient after erythrocyte lysis with ammonium chloride. PMNC were stored in 70% ethanol at −20°C or used directly for DNA isolation. Granulocytes (PMNC) appeared to be more than 95% pure by flow cytometric analysis based on light scattering properties. After thawing in the presence of DNAsel, MNC were washed and stained with mouse monoclonal antibodies for CD19 (PE conjugated) and CD3 (FITC conjugated) (Coulter Immunotech, Marseille, France). Cells were sorted using a Coulter Epics Elite flowcytometer (Beckman Coulter, Fullerton, CA, USA). T cells were defined as CD3 positive, CD19 negative. Monocytes were defined as CD3 and CD19 negative, and having the appropriate scattering characteristics. After sorting, the cells were prepared for DNA isolation.
DNA isolation, Hpall digestion and PCR
DNA from all cells was isolated with the Puregene DNA isolation kit (Gentra Systems, Minneapolis, MD, USA). DNA was diluted to 0.1 g/l. Digestion of 5 l of a DNA sample was performed overnight at 37°C in a reaction mixture of 25 l, containing 25 units of concentrated HpaII (New England Biolabs, Hitchin, UK) with or without 5 units DdeI or 5 units RsaI (Life Technologies, Gaithersburg, MD, USA) in 1 × one-phorall buffer PLUS (Amersham Pharmacia, Uppsala, Sweden). After digestion, 5 l of this mixture was used for PCR amplification of the HUMARA locus. The PCR mixture contained 300 nM forward primer, 400 nM FITC-labeled reverse primer, 6% DMSO, 2.5 mM dNTPs (Amersham Pharmacia), 1.5 mM MgCl 2 , 1 × buffer II and 1.25 units AmpliTaq Gold (Applied Biosystems, Foster City, CA, USA) in a total reaction mixture of 50 l. Primer sequences were: forward 5Ј-ccccaggcacccagaggc-3Ј, reverse 5Ј-gagaaccatcctcaccctgct-3Ј. PCR was performed based on a protocol by Mutter et al: 5 7.5 min 95°C, followed by three rounds of 2.5 min 95°C, 30 s 62°C, 1 min 71°C, followed by 32 rounds of 45 s 95°C, 30 s 62°C, 1 min 72°C, followed by a single step of 10 min 72°C.
Analysis of PCR products
PCR products were analyzed by electrophoresis on agarose or acrylamide gels, and the relative abundance of the alleles was quantified. Analysis was performed on 4% agarose E-gels (Invitrogen, Carlsbad, CA, USA). If the relative abundance of either allele was more than 75%, or if the difference in size was less than two repeats (6 bp), analyses were repeated on acrylamide gels. The relative abundance of alleles was quantified using a Gel Doc 1000 UV detection system and Multi
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Analyst software (Biorad, Hercules, CA, USA) for agarose gels. Acrylamide analysis was done using POP-4 acrylamide, genetic analyzer buffer and '310' capillaries (Applied Biosystems) in a P/ACE 5000 capillary electrophoresis system equipped with a LIF detector and an argon laser at 488 nm (Beckman Coulter) or in a ABI PRISM 310 genetic analyzer (Applied Biosystems). Reliability of quantification was tested by diluting two male DNA samples into each other (with different sizes of alleles). Ratios between 20:80 and 80:20 gave identical results for agarose and acrylamide analysis. More extreme ratios were quantified more reliably with acrylamide electrophoresis; due to the higher background on agarose gels low intensity bands are overestimated leading to inaccurate quantification of extreme ratios. The presence of heteroduplexes on agarose gels did not influence the ratio of the correct bands. The correlation for the dilution series on acrylamide was 0.9927 (R 2 ). Duplicates were always within 10% of each other. All samples were analyzed at least in duplicate. Several samples were analyzed after independent HpaII digestion or independent cell sorting, and these always gave results within 10% of previous experiments. The PCR ratio was calculated by dividing the signal of the largest allele by the total signal of both alleles and multiplying with 100%, unless otherwise indicated. Skewing was defined as a ratio more extreme than 75:25 or 25:75.
Results
Skewing in total genomic DNA and HpaII digested DNA
The ratio of paternal and maternal alleles of the X-chromosome in genomic DNA should theoretically be 50:50 after amplification of the HUMARA locus (PCR ratio). In the initial phase of the study we found an unequal amplification of alleles (more extreme than 60/40) in the genomic DNA of peripheral granulocytes. This was observed in eight out of 12 cases with a skewed XCIP after HpaII digestion. The PCR ratio was in opposite directions before and after HpaII digestion in all these cases (Table 1 ). This suggests a less efficient amplification of the inactivated, methylated alleles. To improve the HUMARA PCR and to make the DNA more accessible we digested the DNA of two donors (with equal, DN13, or unequal, DN11, PCR ratios) with DdeI or RsaI and with or without HpaII prior to PCR (Figure 1 ). DdeI and RsaI are methylation-insensitive enzymes that cut outside the HUM-ARA PCR target. The already balanced PCR ratio of DN13 was 6) . The addition of DdeI digestion in the HUMARA protocol reduced unbalanced amplification of genomic DNA to less than 1% of cases (two out of 263). Consequently we used the PCR ratio of the HpaII + DdeI digested DNA as the most reliable value for XCIP. Cases were not evaluated in which the PCR ratio after DdeI digestion alone was more than 60% or less than 40%.
Skewing in relation with age
Peripheral blood samples of 35 healthy blood donors were assessed for their XCIP. In Figure 2 we have plotted the XCIP value of the allele with the most intensity for each donor
Figure 2
Skewing increases with age. Plotted are the HUMARA PCR ratios after HpaII and DdeI digestion against the age of each donor. The PCR ratio is given as the percentage of the most abundant allele. All points are the means of at least duplicates. against age. We found, as has been described before, that the prevalence of skewing of granulocytes increases with age and that there is a trend towards a higher degree of skewing with increasing age. In the youngest group of donors (aged between 20 and 23), we found no cases of skewing (ratio more extreme than 75:25). The average PCR ratio in this group was 64% (54-74%). In the age group between 43 and 55, four out of 12 donors (25%) had a skewed XCIP of more than 75%. The average PCR ratio in this group was 70% (52-88%). In the eldest group (age between 61 and 67) six out of 15 (40%) donors had a skewed XCIP of more than 75%. The average PCR ratio in this group was 73% (50-97%). The average PCR ratio was only statistically different between the young and the old group (P = 0.04).
X-chromosome inactivation patterns over time in granulocytes
Twenty-six of the 35 healthy donors, in three different age groups, were evaluated at multiple time points for fluctuations in their XCIP. Changes in the XCIP of granulocytes of more than 20% have not been observed in any of the donors. In the young age group six out of eight individuals were evaluated for their XCIP in granulocytes at multiple time points. The median follow-up time in this group was 7 months, ranging from 4 to 13 months. The mean variation between samples was 3%, ranging from 1 to 7%. In the middle-aged group eight out of 12 individuals were evaluated at multiple time points with a mean follow-up time of 12 months (4.5-18). The mean variation in this group was 3% (0-7%). In the elderly donor group 12 out of 15 donors were evaluated at multiple time points. The mean fluctuation in XCIP in this group was 7% (0-18%), the mean follow-up time was 13 months (4.5-18). The age, follow-up time and the variation between samples are given for each donor in Figure 3 . The median time between samples was 4.8 months for the whole group (2 weeks-18 months).
Granulocytes compared to monocytes and T cells
The XCIP in the monocytes, T cells and granulocytes was compared in 25 of the 35 donors. We tested 14 of the 15 elderly, nine of the 12 middle-aged and two of the eight young donors, in view of the more prevalent skewing in granulocytes of the older donors. The average XCIP value for all three cell types are plotted in Figure 4 for all 25 donors. Also in these cell fractions no fluctuations of more than 20% in XCIPs were found with one exception. In donor 9 a single time point showed a significant difference in XCIP in the T cells as compared to samples of other time points, after multiple analyses (Figure 5a ). The granulocytes of the same sample did not show this fluctuation.
The mean difference between monocytes and granulocytes of the same donor was 2% and the difference was always less than 20%. In general, T cells had less extreme XCIPs than granulocytes. Eighteen out of 25 cases showed less extreme skewing of XCIP in T cells than in granulocytes, with an average difference of 14% (1-45%). In seven cases T cells showed more extreme skewing than granulocytes, with a mean difference of 6% (1-12%). In six cases granulocytes had an XCIP value of more than 75% while the T cells had an XCIP value of less than 75%. Of these, a difference of more than 20% in XCIP between T cells and non-T cells was observed in only three cases (Figure 5c ). Interestingly, in six donors a difference was seen between T cells and non-T cells that was less than 20%, but remained stable for up to 17 months with analyses at four different time points (Figure 5d ).
Discussion
Acquired skewing of XCIP in hematopoietic cells cannot be distinguished from malignant, clonal hematopoiesis in elderly females with the tests that are available today. We investigated if the skewed XCIP in elderly females is prone to fluctuations, in order to distinguish normal, skewed hematopoiesis from monoclonal, malignant hematopoiesis. Fluctuations in XCIP are conceivable if we assume the size of the active stem cell pool to decrease with age. Skewed hematopoiesis may occur by chance if the pool of active stem cells is sufficiently small. Fluctuations in XCIP in such a small stem cell pool are likely to occur if we assume this pool to be part of a larger, nonskewed, resting stem cell pool, with cells switching between
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Figure 4
Average XCIP of granulocytes, monocytes and T cells. The XCIP, represented by the PCR ratio after HpaII and DdeI digestion, is plotted for the granulocytes, monocytes and T cells of 25 donors. The values for the different cell types of the same donor are connected. All points are the means of at least duplicates.
active or resting status. In mice, a study by Cheshier et al 16 estimated the switching of stem cells between active and inactive status to be 8% per day. The authors also showed that 99% of stem cells enter cell cycle at least once in 57 days, implying that fluctuations, if they occur, should be evident within a few months. However, a study by Abkowitz et al 17 showed a difference between hematopoietic stem cells (HSC) from murine and feline origin. A difference was observed in the number of HSC (eight HSC per 10 5 nucleated bone marrow cells (NBMC) and six HSC per 10 7 NBMC, respectively) and in HSC replication (one replication per 2.5 weeks and one replication per 8.3 to 10 weeks, respectively). Wang et al 18 estimated the number of HSC in humans to be even less frequent (one HSC per 10 7 NBMC). If fluctuations do occur in the XCIP of the active stem cell pool, these fluctuations should be reflected in the XCIP of peripheral granulocytes.
However, we did not observe fluctuations in the XCIP of leukocytes of any donor during a follow-up of up to 18 months. The only exception was UDN 9, whose T cells showed a fluctuation in XCIP. This does not reflect a fluctuation of the XCIP of the active stem cells at that moment, as the granulocytes at that time point did not show this fluctuation. More likely is the explanation that this sudden skewing in the T cells was the result of an expansion of one particular T cell clone due to an infection. Abkowitz et al 19 showed that in cats skewing of XCIP of hematopoietic cells arises gradually during life without the occurrence of fluctuations from one allele to the other. Furthermore, Tonon et al 10 observed that the XCIP of hematopoietic cells remain stable for a period of 12 to 24 months in healthy human donors. However, the authors did not present data on the number or the age of individuals, nor on the number of samples that were tested. If fluctuations do occur after all, they occur with such a low frequency that they are not of practical use. The lack of fluctuations could imply that the active stem cell population does not decrease sufficiently for fluctuations to become apparent or that fluctuations occur much slower. Another explanation for the lack of fluctuations in our study is acquired skewing affecting the whole of the stem cell compartment. This could be caused by clonal drift due to a stochastic process. 9 Other explanations are based on genetic differences. A somatic mutation may lead to clonal domination of a single cell, as is the case in malignant hematopoiesis. Alternatively, polymorphisms in genes located on the X-chromosome may lead to selection of cells with one particular active X-chromosome and to a skewed XCIP. 7, 8 Such polymorphisms should be present in genes regulating the decision of self-renewal or differentiation after stem cell division, or in genes affecting growth rate or survival of cells. Abkowitz et al 19 have shown in cats that acquired skewing of XCIP is likely to be caused by a polymorphic gene on the X-chromosome. Recently Christensen et al 20 showed that this is also the case in humans through a study of XCIPs in elderly, monozygotic twins. The authors showed that the XCIP of the majority of co-twins was skewed in the direction of the same allele. In addition, the degree of skewing between co-twins was strongly correlated. Also, Vickers et al 21 showed a genetic influence on the development of acquired skewing in human peripheral blood granulocytes. These findings correlate well with the lack of fluctuations in XCIP in time. It also makes it less likely that very slow fluctuations occur that we would have missed in our study.
One of the reported problems with the HUMARA assay for the assessment XCIP is unequal amplification of alleles. 5, 6 As the HUMARA alleles differ in the number of CAG repeats in exon 1, the shortest allele may be preferentially amplified during PCR. For this reason, genomic DNA is generally amplified along with the HpaII digested DNA, as the unequal amplification might be similar in both samples. However, in the initial phase of our study we only observed skewed PCR ratios in genomic DNA when there was also skewing in the HpaII digested DNA. Furthermore, this skewing was always in the opposite direction compared to the skewing in the HpaII digested DNA. This implied that there is a difference in amplification efficiency between the DNA of the methylated Xchromosome and other DNA. Such a phenomenon is only apparent in skewed samples, where the ratio of maternal and paternal alleles in the inactivated X-chromosomes is exactly opposite to the ratio in the active X-chromosomes. Digesting the DNA with DdeI results in excision of a 523 bp fragment from the X-chromosome that contains the HUMARA PCR locus. This digestion fully prevented the unequal amplification. When the genomic DNA was digested with DdeI, the PCR ratio was almost always 50% (with an error margin of 10%), even when the XCIP was extremely skewed. In rare cases (two out of 263) we still observed an unbalanced amplification in the genomic DNA of more than 60% of either allele. In these cases contaminating salts could influence the amplification of alleles. 5 Alternatively, the difference in length of alleles could indeed lead to a different amplification efficiency in these cases. 6 We decided to exclude these samples from our analysis.
We conclude that the XCIPs of leukocytes of elderly healthy females do not fluctuate in time, and that the development of a skewed XCIP is a slow, gradual process. This means that no distinction can be made between normal skewed hematopoiesis and clonal, malignant hematopoiesis in elderly females based on fluctuations in the XCIP. However, the HUMARA PCR can still be useful for XCIP studies in younger females and in the investigation of solid tumors. Secondly, we conclude that our improved HUMARA PCR leads to a more reliable determination of XCIPs.
